J
James S. Babb
Researcher at New York University
Publications - 369
Citations - 28256
James S. Babb is an academic researcher from New York University. The author has contributed to research in topics: Magnetic resonance imaging & Diffusion MRI. The author has an hindex of 84, co-authored 360 publications receiving 24937 citations. Previous affiliations of James S. Babb include University of York & Fox Chase Cancer Center.
Papers
More filters
Journal ArticleDOI
Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody
M. Zahidunnabi Dewan,Ashley E. Galloway,Noriko Kawashima,J. Keith DeWyngaert,James S. Babb,Silvia C. Formenti,Sandra Demaria +6 more
TL;DR: Fractionated but not single-dose radiotherapy induces an abscopal effect when in combination with anti–CTLA-4 antibody in two preclinical carcinoma models.
Journal ArticleDOI
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Sandra Demaria,Bruce Ng,M. Devitt,James S. Babb,Noriko Kawashima,Leonard Liebes,Silvia C. Formenti +6 more
TL;DR: The results demonstrate that the abscopal effect is in part immune mediated and that T cells are required to mediate distant tumor inhibition induced by radiation.
Journal Article
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging
Meng Law,Stanley Yang,Hao Wang,James S. Babb,James S. Babb,Glyn Johnson,Soonmee Cha,Edmond A. Knopp,David Zagzag +8 more
TL;DR: The rCBV measurements had the most superior diagnostic performance (either with or without metabolite ratios) in predicting glioma grade and can be used in a clinical setting to evaluate tumors preoperatively for histologic grade and provide a means for guiding treatment and predicting postoperative patient outcome.
Journal Article
Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.
Sandra Demaria,Noriko Kawashima,Anne Marie Yang,M. Devitt,James S. Babb,James P. Allison,James P. Allison,Silvia C. Formenti +7 more
TL;DR: The combination of local RT with CTLA-4 blockade is a promising new immunotherapeutic strategy against poorly immunogenic metastatic cancers.
Journal ArticleDOI
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.
Satoko Matsumura,Baomei Wang,Noriko Kawashima,Steve Braunstein,M. Badura,Thomas O. Cameron,James S. Babb,Robert J. Schneider,Silvia C. Formenti,Michael L. Dustin,Sandra Demaria +10 more
TL;DR: It is demonstrated that IR markedly enhanced the secretion by mouse and human breast cancer cells of CXCL16, a chemokine that binds to CXCR6 on Th1 and activated CD8 effector T cells, and plays an important role in their recruitment to sites of inflammation.